Progressive Corp. (PGR) Misses Q2 EPS by 32c

Progressive Corp. (NYSE: PGR) reported Q2 EPS of $0.57, $0.32 worse than the analyst estimate of $0.89. Revenue for the quarter came in at $14.72 billion versus the consensus estimate of $15.01 billion.

For earnings history and earnings-related data on Progressive Corp. (PGR) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
• Ascendis Pharma (ASND) Tops Q2 EPS by 132c